PTAB Grants Kyle Bass' Bid To Review Acorda Drug Patents
The Patent Trial and Appeal Board on Friday granted requests by a group with close ties to hedge fund manager Kyle Bass to review the validity of four Acorda Therapeutics Inc....To view the full article, register now.
Already a subscriber? Click here to view full article